Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone

Update Il y a 5 ans
Reference: NCT00449553

Woman and Man

Extract

The purpose of this study is to asses changes in glycosylated hemoglobin, fasting blood lipids and genetic polymorphism's in peroxisomal proliferator activated receptors--gamma receptor after 6 months of pioglitazone, once daily (QD), treatment.


Inclusion criteria

  • Diabetes Mellitus


Links